What Depression Does to Brain Chemistry

The most familiar story about depression involves serotonin: not enough of it, and mood suffers. That account is not wrong, but it is incomplete. Depression disrupts multiple neurotransmitter systems simultaneously, and the downstream consequences extend well beyond how a person feels on a given day.

Among the most significant changes is what happens to BDNF (brain-derived neurotrophic factor), a protein that supports the growth, survival, and maintenance of neurons (brain cells). In people with depression, BDNF levels are often markedly reduced. This matters because BDNF is essentially the brain’s maintenance crew: without adequate levels, neurons in mood-regulating regions begin to atrophy, synaptic connections weaken, and the brain’s capacity to adapt and recover is compromised. Research has shown that ketamine directly increases BDNF, which may explain part of its rapid antidepressant effect (National Institutes of Health).

The hippocampus, a brain region central to memory formation and emotional regulation, is particularly vulnerable to these changes. Studies show that prolonged depression can actually reduce hippocampal volume, contributing to the memory difficulties and cognitive fog that many patients describe alongside low mood (National Institutes of Health). For Silicon Valley professionals who rely on sharp thinking, this aspect of depression’s neurological footprint is often deeply disruptive.

The Glutamate Gap That SSRIs Don’t Fill

First-line antidepressants, SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors), work by increasing the availability of serotonin and norepinephrine at synapses. They help a significant portion of people with depression, and we respect their role in treatment (National Institutes of Health). But they operate on a specific subset of the brain’s chemistry, and for patients whose depression involves substantial glutamate system dysregulation, serotonin-targeted treatment may simply not be addressing the right problem.

Glutamate is the brain’s primary excitatory neurotransmitter, it drives the vast majority of signaling between neurons. When the glutamate system is dysregulated, as appears to be the case in many forms of treatment-resistant depression, the brain loses some of its capacity for neuroplasticity: the ability to form new connections, reorganize existing pathways, and recover from damage. This is the gap that has made a growing number of clinicians and patients look past the standard antidepressant toolkit.

At Soft Reboot Wellness, Dr. Sara Herman, a Harvard-trained anesthesiologist who has guided more than 10,000 patients through anesthesia and ketamine therapy, built our practice around this understanding. The patients who find their way to us have frequently tried multiple antidepressants, often for years, and still feel stuck. Their experience is not a failure of willpower; it reflects a biological reality about which neurotransmitter systems their depression is actually engaging.

How Neuroplasticity Becomes the Target

Neuroplasticity, the brain’s ability to reorganize itself by forming new neural connections, is not a static trait. It can be increased or decreased by environment, stress, illness, and treatment. Chronic depression is one of the more reliable ways to suppress it; effective treatment for depression is one of the more reliable ways to restore it.

Research shows that ketamine promotes neuroplasticity in ways that standard antidepressants do not, and does so rapidly, changes that SSRIs typically require weeks to approximate can appear within hours of a ketamine infusion (National Institutes of Health). This speed is clinically meaningful. For someone in the grip of severe depression, a week matters. For someone who has been waiting for months across multiple medication trials, the prospect of a different timeline is significant.

The mechanism behind this rapid effect runs through NMDA receptor blockade and the subsequent release of glutamate in a pattern that activates neuroplasticity pathways. In plain terms: ketamine briefly disrupts the brain’s usual signaling, and when that disruption resolves, the brain rebuilds connections in a healthier pattern. It is a reset, not a permanent fix achieved in a single session, but a meaningful opening that, with appropriate integration support, can be built upon.

What This Means for Treatment-Resistant Depression

For patients who have not responded to two or more antidepressant trials, the neuroscience strongly suggests the problem is not that they haven’t found the right serotonin medication. The problem may be that the serotonin system is not the primary driver of their depression at all.

Our IV ketamine infusions at Soft Reboot Wellness target the glutamate system directly, bypassing the serotonin pathway entirely and addressing the neuroplasticity deficit that standard medications leave untouched. A standard induction series involves four to six infusions over four to six weeks, with the protocol personalized to your response. We use the Osmind EHR platform for mood tracking throughout, so progress is documented rather than impressionistic. For patients who want to use the neuroplastic window opened by ketamine for deeper psychological work, our ketamine-assisted psychotherapy (KAP) program adds a preparation session and integration coaching.

We also work closely with patients’ existing treatment teams. If you have a psychiatrist or therapist, we coordinate with them, with your permission, because the neurobiological changes ketamine may produce are best consolidated through ongoing therapeutic work. Results vary by individual, and we encourage you to discuss whether ketamine therapy is appropriate for your specific history with your current healthcare provider.

Addressing the Fear of Starting Something New

One barrier we hear from patients often is not skepticism about the science. It is the exhaustion that comes from having tried things before and having them not work. After multiple medication trials, hope becomes a liability that feels too expensive to extend again.

We understand that. Dr. Herman and our team approach every new patient with the awareness that they are arriving with a history, not just a diagnosis. The initial intake process is designed to give us a thorough picture of what you have tried, for how long, and how you responded, so our recommendations are grounded in your actual trajectory, not a generic protocol. Treatment is not appropriate for everyone, and we will tell you honestly if we do not think we are the right fit.

The cost of ketamine therapy is a real consideration. IV ketamine for mental health is an off-label treatment, and insurance coverage is not standard. We recommend contacting our team at hello@softrebootwellness.com or 650-419-3330 to discuss the financial realities before your consultation, so there are no surprises on either side of the conversation.

Frequently Asked Questions

Can depression actually shrink your brain? Research suggests prolonged depression is associated with reduced volume in the hippocampus and other mood-regulating regions, likely due to the neurotoxic effects of chronic stress hormones and reduced BDNF levels (National Institutes of Health). These changes are not necessarily permanent, effective treatment, including approaches that promote neuroplasticity, may help restore some of this lost volume over time. Results vary by individual.

Why do antidepressants take so long to work if depression is a brain chemistry problem? SSRIs and SNRIs modulate neurotransmitter availability gradually, and the downstream structural changes that correspond with symptom improvement, including neuroplasticity shifts, take weeks to develop. The delay is a function of how those medications work at the synaptic level. Ketamine’s mechanism differs: it triggers a rapid glutamate release and neuroplasticity cascade that can produce antidepressant effects much faster, often within hours of infusion (National Institutes of Health).

Does everyone with depression have glutamate dysregulation? Not necessarily. Depression is not a single condition with a single mechanism. Glutamate dysregulation appears to be more prominent in treatment-resistant presentations, people who have not responded to serotonin-targeting medications. This is part of why we conduct a thorough review of your treatment history before recommending IV ketamine therapy.

How does cognitive fog from depression relate to brain changes? The memory and concentration difficulties many people experience with depression are tied to the same neurobiological changes that affect mood, particularly reduced hippocampal function and BDNF depletion. Effective treatment that addresses these underlying mechanisms may improve cognitive symptoms alongside mood, though results vary significantly between individuals.

Key Takeaways

• Depression produces measurable changes in brain chemistry and structure, including reduced BDNF, hippocampal atrophy, and glutamate system dysregulation. It is not simply a mood state.
• Standard antidepressants target the serotonin and norepinephrine systems; they may not adequately address glutamate dysregulation, which is common in treatment-resistant presentations.
• Neuroplasticity, the brain’s capacity to form new connections, is suppressed by chronic depression and can be rapidly restored by ketamine infusion.
• Our IV ketamine therapy at Soft Reboot Wellness in Menlo Park directly targets the glutamate-neuroplasticity pathway that many patients have not yet addressed.
• Results vary by individual; treatment candidacy is determined through a thorough medical and psychiatric review.

If your depression has not responded the way you hoped to standard treatment, the neuroscience suggests you are not broken, you may simply need treatment that works on a different system. We are glad to talk through whether that is something we can help with. Call us at 650-419-3330 or email hello@softrebootwellness.com to start the conversation.

References

1. Mayo Clinic. Symptoms and causes of major depressive disorder. https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007
2. National Institutes of Health. Ketamine promotes neuroplasticity, the brain’s ability to form new neural connections, which may explain its rapid and sustained antidepressant effects. https://pmc.ncbi.nlm.nih.gov/articles/PMC8190578/
3. National Institutes of Health. Ketamine has been shown to increase brain-derived neurotrophic factor (BDNF), a protein essential for neuron growth and long-term mood regulation. https://pubmed.ncbi.nlm.nih.gov/39684808/
4. National Institutes of Health. Research documents the efficacy and limitations of SSRIs as a first-line treatment for depression and anxiety. https://pmc.ncbi.nlm.nih.gov/articles/PMC8395812/
5. National Institutes of Health. Research shows depression can impair memory and cognitive function, which may be improved with effective treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC5835184/

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Treatment for depression, including IV ketamine therapy, should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

Reviewed by Dr. Sara Herman

The post How Depression Changes Your Brain: The Neuroscience Explained appeared first on Soft Reboot Wellness.

The Glutamate System: The Story Standard Care Underemphasizes

When researchers began looking seriously at why antidepressants work for some people and not others, attention shifted toward a neurotransmitter most patients have never heard of: glutamate. Unlike serotonin, which modulates mood as one signal among many, glutamate is the brain’s primary excitatory neurotransmitter, responsible for the vast majority of signaling between neurons (National Institutes of Health). It is involved in learning, memory, synaptic plasticity, and the brain’s ability to reorganize itself in response to experience.

In a healthy brain, glutamate signaling operates within a careful balance. In a depressed brain, that balance is disrupted, and the consequences ripple outward. The NMDA receptor (N-methyl-D-aspartate receptor), which sits at the center of glutamate signaling and plays a central role in synaptic plasticity, begins to malfunction (National Institutes of Health). Synaptic plasticity is the technical term for the brain’s capacity to strengthen or weaken the connections between neurons depending on how they are being used, the mechanism underlying learning, adaptation, and recovery. When NMDA receptor function falters, the brain loses some of this adaptability, and mood regulation suffers in ways that serotonin-targeting medications do not directly address.

This is not a niche theory. It is increasingly the central explanation for why treatment-resistant depression exists at all, and it is the scientific basis for why ketamine, which works primarily through NMDA receptor blockade, has attracted such serious clinical interest over the past two decades. For a deeper look at the brain changes depression produces, see our post on what depression does to the brain.

What Memory Difficulties Are Telling You

Many people with depression report that their cognition changes alongside their mood. Words come more slowly. Concentration requires effort that used to be effortless. Past memories feel dulled or inaccessible. These are not separate symptoms from the depression. They are part of the same underlying neurobiology (National Institutes of Health).

The hippocampus, a brain structure critical to memory formation and retrieval, is particularly sensitive to the stress hormones elevated in chronic depression. Over time, high cortisol (the primary stress hormone) damages neurons in the hippocampus, contributing to the cognitive symptoms that many patients find as debilitating as the emotional ones. For professionals in Silicon Valley, where cognitive performance is closely tied to professional identity and career functioning, this aspect of depression often carries its own separate weight.

Understanding that these cognitive difficulties have a biological basis, that they are not a character issue or a sign of diminished capability, is something we address directly with patients at Soft Reboot Wellness. The brain changes that depression produces are real, measurable, and in many cases reversible with treatment that targets the right systems.

Why SSRIs Leave a Gap for Some Patients

SSRIs, selective serotonin reuptake inhibitors, work by blocking the reabsorption of serotonin into neurons, keeping more of it active in the space between cells. They are a genuine first-line treatment option and help many people significantly (National Institutes of Health). But they do not touch the glutamate system. They do not directly address NMDA receptor dysfunction. And they typically require six to eight weeks before any meaningful clinical effect is evident, a timeline that reflects the slow, indirect path through which serotonin changes eventually influence neuroplasticity. For a detailed comparison of how ketamine and SSRIs differ mechanically, see our post on ketamine versus SSRI treatment.

For a patient whose depression is primarily driven by glutamate dysregulation and reduced synaptic plasticity, this means that even a well-chosen, well-tolerated SSRI at the right dose may simply be pulling a lever that isn’t connected to the problem. This is not a failure of the medication. It is a mismatch between mechanism and condition.

When patients come to us having tried multiple antidepressants without adequate relief, the working hypothesis we start with is not that the next SSRI or SNRI will be the answer. It is that the serotonin system may not be the primary driver of their depression, and that a treatment targeting glutamate and neuroplasticity directly may be what’s been missing.

What the Depressed Brain Needs to Recover

Recovery from depression, real recovery, not just symptom suppression, requires the brain to rebuild the neural architecture that chronic depression has degraded. This means restoring BDNF (brain-derived neurotrophic factor) levels to support neuron health, repairing synaptic connections in mood-regulating circuits, and re-establishing the kind of glutamate system balance that allows the brain to adapt, learn, and regulate emotion effectively.

Treatment that promotes this kind of recovery works differently than treatment that simply modulates neurotransmitter availability. Ketamine, administered as an IV infusion, blocks NMDA receptors transiently and triggers a downstream release of glutamate in a pattern that activates neuroplasticity pathways, essentially jumpstarting the repair process (National Institutes of Health). The effect is fast by psychiatric standards: many patients report meaningful mood changes within hours of their first infusion, with the neuroplastic effects persisting and consolidating in the days that follow.

At Soft Reboot Wellness, a standard ketamine induction series involves four to six IV ketamine infusions over four to six weeks. Dr. Sara Herman, a Harvard-trained anesthesiologist with Advanced Certificate training in psychedelic-assisted therapy, personally provides and monitors all infusion sessions. We track mood progress through the Osmind platform so you and our team can assess your response objectively rather than relying on memory alone. For patients who want to build on the neuroplastic window the infusions open, our ketamine-assisted psychotherapy (KAP) program adds structured preparation and integration work with a certified psychedelic integration coach.

The Scheduling and Cost Questions

We know that for many patients considering ketamine therapy, the questions are not only neurological. They are practical. How disruptive is this to a work schedule? What does it cost, and will insurance cover any of it?

On scheduling: a ketamine infusion session does not require days of recovery. Most patients return to regular activities the following day, and we offer appointment times designed to accommodate demanding professional schedules. To get started, call or email us directly, we send you an intake packet, Dr. Herman reviews it, and then determines whether to schedule a consultation.

On cost: IV ketamine for mental health is considered an off-label treatment, and insurance coverage is inconsistent. We recommend calling us at 650-419-3330 or contacting us at hello@softrebootwellness.com to discuss costs before your consultation so that financial clarity is part of the decision-making process, not an afterthought. Results vary by individual, and we encourage everyone to discuss their options with their healthcare provider before starting.

Frequently Asked Questions

If my depression involves glutamate, why didn’t my doctor tell me that? Glutamate’s role in depression has become much clearer in the research over the past two decades, but it hasn’t yet shifted mainstream prescribing practice in the same way serotonin science did. Most primary care providers and psychiatrists are appropriately focused on first-line serotonin-targeting medications, which help many patients. The glutamate conversation typically becomes relevant when those first-line options have not produced adequate results. We are happy to discuss where your history fits into this picture during a consultation.

Can the cognitive symptoms of depression, the brain fog and memory issues, improve with treatment? Research suggests they can, particularly when treatment addresses the underlying neurobiological disruption rather than just surface symptoms (National Institutes of Health). The hippocampal changes associated with chronic depression are not necessarily permanent, and treatments that promote neuroplasticity, including ketamine, may support cognitive recovery alongside mood improvement. Results vary significantly between individuals.

Is the glutamate system involved in anxiety as well? Yes. The glutamate and NMDA receptor systems are implicated in anxiety disorders as well as depression, which may help explain why patients with comorbid anxiety and depression sometimes see both improve with ketamine treatment. We treat anxiety at Soft Reboot Wellness and assess the full scope of a patient’s condition during the consultation process.

What makes Soft Reboot different from other ketamine clinics in the Bay Area? Our clinical foundation is built on Dr. Herman’s background as a Harvard-trained anesthesiologist with psychedelic medicine credentials and IFS therapy training, a combination that shapes both the safety standards and the integration approach of our practice. We also work actively with patients’ existing care teams, use structured mood tracking, and offer KAP for patients who want the infusion experience embedded in a broader therapeutic framework. We think the neuroplastic window ketamine opens is best used, not just survived.

Key Takeaways

• The depressed brain shows measurable disruptions in glutamate signaling, NMDA receptor function, and neuroplasticity, changes that serotonin-targeting medications do not directly address.
• Cognitive symptoms like brain fog and memory difficulties are part of the same underlying neurobiology as mood symptoms, not separate complaints.
• SSRIs work well for many patients, but do not directly treat glutamate dysregulation, leaving a gap that IV ketamine therapy is specifically designed to fill.
• IV ketamine at Soft Reboot Wellness in Menlo Park targets the NMDA receptor system, promoting rapid neuroplasticity and BDNF restoration.
• Results vary by individual; treatment is initiated following a thorough medical and psychiatric consultation.

Depression’s grip on the brain is real, but so is the brain’s capacity to change when it gets the right input. If you have been trying to feel better using tools that may not be reaching the right systems, we would like to talk with you about what else may be possible. Reach us at 650-419-3330 or email hello@softrebootwellness.com to start the conversation.

References

1. National Institutes of Health. The glutamate neurotransmitter system is the brain’s primary excitatory system and a key pathway through which ketamine produces its therapeutic effects. https://www.ncbi.nlm.nih.gov/books/NBK62187/
2. National Institutes of Health. NMDA receptors play a central role in synaptic plasticity and are the primary target of ketamine’s antidepressant action. https://pmc.ncbi.nlm.nih.gov/articles/PMC9965111/
3. National Institutes of Health. Research shows depression can impair memory and cognitive function, which may be improved with effective treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC5835184/
4. National Institutes of Health. Research documents the efficacy and limitations of SSRIs as a first-line treatment for depression and anxiety. https://pmc.ncbi.nlm.nih.gov/articles/PMC8395812/
5. National Institutes of Health. Ketamine promotes neuroplasticity, the brain’s ability to form new neural connections, which may explain its rapid and sustained antidepressant effects. https://pmc.ncbi.nlm.nih.gov/articles/PMC8190578/

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Treatment for depression and related conditions, including IV ketamine therapy, should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

Reviewed by Dr. Sara Herman

The post Understanding the Depressed Brain: What’s Really Happening Inside appeared first on Soft Reboot Wellness.

Understanding Seasonal vs. Holiday Depression

The confusion between holiday depression and seasonal affective disorder runs deep in our cultural understanding of winter mental health. Seasonal affective disorder, or SAD, follows a predictable pattern tied to light exposure and circadian rhythms. According to the National Institute of Mental Health, SAD is specifically related to changes in daylight hours, not calendar events or social stressors. The biological mechanisms involve disrupted serotonin and melatonin levels that throw off your body’s natural daily rhythms.

Holiday depression, by contrast, emerges from the psychological and social pressures unique to this time of year. It’s triggered by family dynamics, financial stress, grief over lost loved ones, social isolation, or the gap between holiday expectations and reality. The American Psychological Association’s 2023 research revealed that 89% of adults feel stressed during holidays, with primary concerns including gift expenses, family gatherings, and managing multiple obligations rather than light-related factors.

Consider the timing differences. True seasonal depression typically begins in late fall and continues through winter, following the sun’s patterns. Holiday depression might start in November with Thanksgiving stress, peak during December’s chaos, and actually improve after New Year’s despite winter’s continuation. Some people feel worse on bright, sunny December days when everyone else seems cheerful, which wouldn’t happen with light-sensitive SAD.

The symptom patterns also diverge in telling ways. Seasonal depression usually involves increased appetite, carbohydrate cravings, hypersomnia, and weight gain. Holiday depression more often presents with anxiety, insomnia, appetite loss, and agitation. You might find yourself dreading social events rather than simply feeling sluggish, or experiencing specific anxiety about family interactions rather than general energy depletion.

Why the Distinction Matters for Treatment

For high-achievers in Silicon Valley, these distinctions become particularly relevant. The tech industry’s year-end intensity creates a perfect storm where professional pressure collides with personal expectations. You’re managing Q4 deadlines while trying to maintain family relationships, often across different time zones. The cultural emphasis on optimization and metrics can make holiday “failures” feel especially acute.

Dr. Sara Herman at Soft Reboot Wellness, with her Harvard and Columbia training plus over twelve years of ketamine experience, frequently sees this pattern in her Bay Area practice. The professionals who walk through her Menlo Park doors often describe feeling fine during summer vacations but struggling specifically with December’s competing demands. Their symptoms align more with acute stress responses than the predictable seasonal patterns of light-related depression.

Geographic factors compound this complexity in Northern California. While regions like Alaska or Maine see dramatic daylight changes that clearly trigger SAD, the Bay Area’s relatively mild winter and consistent daylight make seasonal patterns less obvious. When someone in Palo Alto feels depressed in December, it’s more likely related to holiday stressors than insufficient light exposure.

The treatment implications of this distinction are significant. Light therapy, the gold standard for seasonal depression, won’t address holiday-specific triggers like family conflict or financial pressure. Traditional antidepressants take weeks to work, often missing the acute holiday window entirely. This is where rapid-acting treatments become particularly valuable.

Recognizing Holiday-Specific Patterns in Silicon Valley

Recent advances in understanding neuroplasticity have revealed why some people struggle specifically with holiday contexts. The brain regions involved in stress response, emotional regulation, and social cognition can become dysregulated under holiday pressures in ways that differ from seasonal patterns. Research by Güler Öztekin and colleagues in 2025 showed how future anxiety and psychological inflexibility contribute to depression and stress, particularly relevant for achievement-oriented individuals facing year-end pressures.

The Internal Family Systems approach that Dr. Herman integrates with ketamine therapy addresses these holiday-specific dynamics directly. IFS recognizes that family gatherings can activate old patterns and “parts” of ourselves that create internal conflict. When combined with ketamine’s rapid neuroplasticity effects, this approach can help people process holiday triggers in real-time rather than waiting months for traditional therapy to take effect.

Identifying Your Personal Depression Pattern

Practical steps you can take this week include tracking your mood patterns to identify whether they correlate with light changes or holiday-specific events. Notice if you feel worse before family gatherings versus on random winter days. Pay attention to whether your symptoms improve on sunny winter days or if they persist regardless of weather.

Another immediate strategy involves separating holiday obligations from genuine seasonal needs. If you feel energetic on January 2nd despite identical daylight hours to December 15th, you’re likely dealing with holiday-specific stress rather than seasonal depression. This awareness can guide your treatment decisions.

Finally, consider your support systems during holiday times versus regular winter periods. Do you feel isolated specifically around family events, or do you crave more social connection throughout winter? This distinction helps determine whether you need holiday-coping strategies or seasonal depression treatment.

Rapid-Acting Treatment Options for Holiday Depression

The reality is that many people experience both seasonal and holiday factors simultaneously, which is why comprehensive assessment matters. At Soft Reboot Wellness, the approach involves understanding your specific pattern before recommending treatment. Some clients benefit from addressing holiday-specific trauma and family dynamics, while others need support for light-sensitive seasonal patterns.

Results vary significantly based on individual circumstances, and no treatment approach guarantees specific outcomes. However, recognizing whether your December struggles stem from holiday stressors or seasonal biology helps guide more targeted interventions. The rapid-acting nature of treatments like ketamine-assisted therapy can provide relief during the actual holiday window rather than requiring you to wait until spring.

Moving Forward with Targeted Support

If you’re experiencing persistent sadness, anxiety, or other mental health concerns during the holiday season, professional evaluation can help distinguish between seasonal and holiday-specific factors. Understanding what you’re actually dealing with is the first step toward finding relief that matches your particular situation.

Whether your December struggles stem from family dynamics, achievement pressure, or genuine seasonal factors, effective treatment options exist. The key lies in accurate assessment and approaches that can work within the holiday timeframe when you need them most.

References:

National Institute of Mental Health. (2024). Seasonal Affective Disorder. Retrieved from https://www.nimh.nih.gov/health/publications/seasonal-affective-disorder

American Psychological Association. (2023). Holiday 2023 Stress Outlook. Retrieved from https://www.apa.org/news/press/releases/2023/11/holiday-season-stress

Güler Öztekin, G., Gómez-Salgado, J., & Yıldırım, M. (2025). Future anxiety, depression and stress among undergraduate students: psychological flexibility and emotion regulation as mediators. Frontiers in Psychology, 16, 1517441.

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Holiday Depression vs. Seasonal Depression: Why December Sadness Isn’t Always About the Weather appeared first on Soft Reboot Wellness.

Understanding Dissociation

Dissociation is a protective response that can manifest in various ways. You might feel disconnected from your thoughts, emotions, body, or surroundings. It can feel like you’re floating above your life, observing rather than participating. This experience can be unsettling, leaving you feeling numb or emotionally distant.

Recent research reveals that over one-third of people with depression also experience dissociation. Conversely, most individuals who report dissociation also struggle with depression. This co-occurrence is often rooted in childhood trauma, which doesn’t always have to be dramatic. It can stem from emotional neglect, overcontrol, or confusing family dynamics. Understanding this connection is crucial, as it can significantly impact your mental health journey.

The Impact of Childhood Trauma

The link between childhood trauma and the development of both depression and dissociation is profound. When faced with overwhelming experiences, your mind may adopt dissociation as a coping mechanism. This means that the emotional numbness you feel could be a protective response to past pain.

For many, this protective response can make depression harder to treat. Standard medications may not work effectively if the underlying issues are rooted in early trauma. You might find yourself feeling emotionally distant, struggling to trust others, or unable to connect with your feelings. This can create a cycle that feels impossible to break.

Dissociative Depression: A Distinct Subtype

Some researchers propose that dissociative depression may be a distinct subtype of depression that requires thoughtful, trauma-informed care. This means that if you’re experiencing both depression and dissociation, it’s essential to address both aspects in your treatment plan. Screening for dissociation during your mental health assessment can be a game-changer, especially for those with treatment-resistant depression.

At Soft Reboot Wellness, we recognize the importance of a comprehensive approach to mental health. Our trauma-aware, personalized care plans are designed to help you reconnect with your emotions and navigate the complexities of your experiences.

Our Approach to Healing

We utilize IV ketamine therapy as a powerful tool to help you reconnect with your emotions. Ketamine has shown promise in treating depression, particularly when traditional medications have failed. By facilitating emotional reconnection, we aim to help you break free from the numbness that often accompanies dissociation.

Moreover, we believe in the power of collaboration. We partner with your therapist to support integration and long-term recovery. This collaborative approach ensures that you receive the most effective care tailored to your unique needs.

Our programs blend traditional medicine with reflective practices like breathwork, journaling, and mood tracking through Osmind. These integrative practices can help you access deeper healing and foster emotional clarity.

Reflecting on Your Experience

If you’ve ever felt emotionally “checked out” or disconnected from your life, it’s essential to consider whether dissociation may be part of your experience. Recognizing this connection can be the first step toward healing. Remember, you’re not alone, and help is available.

At Soft Reboot Wellness, we’re committed to providing you with the support you need to navigate your mental health journey. Our trauma-informed treatment plans are designed to help you reconnect, heal, and gain emotional clarity.

Take the Next Step

If you’re ready to explore a trauma-informed treatment plan, we invite you to reach out to us at Soft Reboot Wellness. Together, we can work towards a brighter, more connected future.

This content is for informational purposes only and is not a substitute for professional medical advice.

Reviewed by Dr. Sara Herman

The post Discover Why Depression Causes Dissociation appeared first on Soft Reboot Wellness.

Traumatic Brain Injury (TBI): A Multifaceted Challenge
TBI disrupts cognitive, emotional, and physical functioning. Recovery often requires addressing neuroinflammation, autonomic dysregulation, and impaired neuroplasticity. Combining advanced therapies like Ketamine Therapy, Stellate Ganglion Block (SGB), and others creates a synergistic approach for comprehensive recovery.

Ketamine Therapy: Rewiring the Brain for Healing

Ketamine enhances neuroplasticity, resetting dysfunctional neural circuits and reducing neuroinflammation. These effects target key TBI symptoms such as cognitive fog, chronic migraines, and emotional dysregulation.

Key Benefits of Ketamine for TBI:

• Promotes synaptic growth for long-term brain repair.
• Increases Brain-Derived Neurotrophic Factor (BDNF), supporting neural resilience.
• Reduces neuroinflammation, offering both immediate symptom relief and durable recovery.

Research Spotlight:

• Effects of Psychoplastogens on BDNF (Molecular Psychiatry, 2024) highlights ketamine’s role in increasing BDNF levels, which drive synaptic formation and enhance brain repair.
• The Neuroregenerative Potential of Ketamine in Depression: Pathways to Cognitive and Emotional Rehabilitation (Annals of Rehabilitation & Regenerative Medicine, 2024) underscores ketamine’s dual impact on structural and emotional rehabilitation.

Synergy Tip: Pair ketamine with other therapies like SGB to maximize its neuroplastic benefits.

Stellate Ganglion Block (SGB): Resetting the Nervous System

The Stellate Ganglion Block targets the sympathetic nervous system (SNS), helping TBI patients overcome autonomic imbalances like chronic headaches, emotional dysregulation, and cognitive fog.

How SGB Works:

• A local anesthetic is injected near the stellate ganglion in the neck, temporarily calming overactive sympathetic pathways.
• This “reset” reduces neuroinflammation, improves blood flow to the brain, and restores autonomic balance.

SGB’s Role in TBI Recovery:

1. Relieves Chronic Headaches: Calms overactive sympathetic nerves causing post-concussive migraines.
2. Enhances Emotional Stability: Reduces the stress response, improving mood and cognitive clarity.
3. Supports PTSD Recovery: SGB helps address co-occurring post-traumatic stress symptoms common in TBI.

Research Highlight:

• The Effect of Bilateral Cervical Sympathetic Chain Blocks on TBI (Brain Sciences, 2024) demonstrated significant improvement in TBI symptoms following cervical chain blocks.

Synergy in Action: Ketamine + SGB

When combined, ketamine and SGB create an optimal healing environment:

• Ketamine: Enhances neuroplasticity, fostering synaptic growth.
• SGB: Reduces autonomic stress, enabling ketamine’s effects to take root more effectively.

Combined Benefits:

• Faster symptom relief and recovery.
• Enhanced emotional and cognitive stability.
• Long-lasting improvements in brain health.

Additional Therapies for TBI Recovery

1. Neurofeedback:
   • Helps retrain the brain for emotional and cognitive stability.
   • Complements SGB by reinforcing autonomic balance.

   Recommended Providers:

   • Abbey Neurofeedback Clinic (Palo Alto): Offers neurofeedback treatments remotely for added flexibility.
   • Norcal Brain Center (San Jose): Specializes in advanced neurofeedback therapies tailored to individual neurological needs.
2. Hyperbaric Oxygen Therapy (HBOT):
   • Delivers concentrated oxygen to injured tissues, reducing neuroinflammation and enhancing neuroplasticity.

   Recommended Providers:

   • Hyperbaric Oxygen Therapy Center – HH Bay Area (Emeryville/East Bay): A state-of-the-art facility focusing on neurological recovery.
   • Norcal Brain Center (San Jose): Provides HBOT alongside neurofeedback for a comprehensive brain health suite.

Realizing Hope: Comprehensive TBI Recovery at Soft Reboot Wellness

At Soft Reboot Wellness, we offer personalized care plans integrating:

• Ketamine Infusions to unlock neuroplasticity.
• Ultrasound-Guided SGB for autonomic balance.
• Referrals to HBOT and Neurofeedback providers for holistic recovery.

Why Choose Us?
Dr. Sara Herman, MD, ABOIM, combines expertise in Cardiothoracic Anesthesiology and Integrative Medicine to deliver cutting-edge treatments tailored to your recovery journey.

Are you ready to begin your healing journey?
Contact Soft Reboot Wellness in Menlo Park, CA, to explore a personalized treatment plan.

Book a Consultation
Rediscover your potential with a tailored approach to healing.

References

1. Molecular Psychiatry (2024): Effects of Psychoplastogens on BDNF
2. Annals of Rehabilitation & Regenerative Medicine (2024): The Neuroregenerative Potential of Ketamine in Depression
3. Brain Sciences (2024): The Effect of Bilateral Cervical Sympathetic Chain Blocks on TBI
4. Frontiers in Neurology (2024): Hyperbaric Oxygen Therapy in TBI

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Traumatic Brain Injury Recovery: Unlocking the Synergy of Ketamine and Stellate Ganglion Block appeared first on Soft Reboot Wellness.

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Healing Heartbreak: Tools for Nervous System Regulation and Emotional Growth appeared first on Soft Reboot Wellness.

An Underrated Superhero – Ketamine

Despite its reputation as a party drug, ketamine, under the watchful eye of a specialized ketamine doctor, is making groundbreaking strides in the mental health landscape, particularly in the battle against depression, anxiety, and PTSD.

At our ketamine therapy clinic at Soft Reboot Wellness, located conveniently near San Francisco in the Bay Area, we’re using this superpowered anesthetic as a beacon of hope for those for whom traditional treatments have fallen short.

Why Ketamine Therapy is a Game Changer?

Picture this: A person has been struggling with depression for years. They’ve tried every antidepressant, every form of therapy, but the black dog still looms. It’s a common story—one that we at Soft Reboot Wellness are all too familiar with. But this is where ketamine steps in.

By utilizing IV ketamine, we are leveraging an entirely different mechanism to combat depression and related disorders. While traditional antidepressants often target the serotonin system, ketamine works on the glutamate system—a key player in mood regulation. This unique mode of action allows us to help patients who find no relief from conventional antidepressants.

Our ketamine doctor (Dr. Sara Herman, MD, ABOIM) in Menlo Park ensures the process is safe, guided, and tailored to your needs.

In summary, while traditional SSRI antidepressants are often the first recourse for depression, they might not always be the answer. Where they fall short, Ketamine Infusion Therapy can step in, offering hope and renewed possibilities. With our expert team at Soft Reboot Wellness and our patient-focused approach, visitors can experience this transformative treatment in the Bay Area.

Depression is a journey, often a challenging one. But with innovative treatments and the bounty of soothing, engaging places in the Bay Area, it is a journey that doesn’t have to be walked alone. Seeking help is the first step toward recovery.

The transformational impact of Ketamine Therapy can be further understood by referring to this case study: https://ketaminesuccessstories.com/palo-alto-ca-testimonial-ketamine-infusion-therapy-depression/

During a time when mental health is increasingly recognized as vital to overall well-being, this cutting-edge therapy is a game-changer. It’s not just a medical intervention, but a beacon of hope for those traversing the often-lonely road of depression. It’s time to step out of the shadows of mental health stigma and embrace the new dawn of depression treatment which is Ketamine Infusion Therapy.

Depression might cast a long shadow, but remember, every shadow exists only because of the light. In this case, that light could very well be Ketamine Infusion Therapy.

What’s The Best Next Step?

At Soft Reboot Wellness, we understand the toll depression can take on residents in Bay Area. Ketamine has been shown to rapidly reduce symptoms of anxiety and depression, providing relief for those who may have tried other treatments without success. If you or someone you know is struggling with depression symptoms, we encourage you to reach out to us and learn more about how ketamine infusion therapy may be able to help.

Don’t suffer in silence – take the first step towards relief and book a consultation with us today.

References

Let’s Get Health California: Depression is a common and treatable condition – https://letsgethealthy.ca.gov/goals/living-well/mental-health-and-well-being-reducing-adult-depression/

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression, Carlos A. Zarate Jr, MD; Jaskaran B. Singh, MD; Paul J. Carlson, MD; et al. NCT00088699, August 2006 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/668195

FAQs

What is Ketamine IV Therapy, and how does it help treat depression symptoms?

Individuals who have not found relief with traditional antidepressants like SSRIs may benefit from Ketamine Infusion Therapy. Ketamine works on the NMDA receptors in the brain and helps to build new neural connections, effectively ‘rebooting’ the brain’s depressive state and offering a fresh start. This treatment is causing a significant shift in how depression is managed.

Why might someone consider Ketamine Infusion Therapy over standard SSRIs for treating depression?

People suffering from depression symptoms often choose selective serotonin reuptake inhibitors (SSRIs) for treatment. Medications of this kind increase serotonin levels in the brain, which affects mood, sleep, appetite, and other functions. The use of SSRIs may not alleviate depressive symptoms or bring back joy to the life of some individuals, however. In such cases, Ketamine Infusion Therapy can offer an alternative treatment that has shown promising results.

How is Ketamine Infusion Therapy accessible for individuals suffering from depression in the Bay Area, near San Francisco, California?

Soft Reboot Wellness, located near San Francisco, California, offers Ketamine Infusion Therapy as part of our patient-focused approach to treating depression. Our expert team provides this innovative treatment, offering hope and renewed possibilities for individuals grappling with depression. Alongside medical interventions, the scenic locales of San Francisco, such as the Redwood Grove Nature Preserve, can also contribute to the overall healing journey.

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Best Ketamine Clinic in the Bay Area: The New Frontier in Mental Health Treatment appeared first on Soft Reboot Wellness.

Palo Alto Daily Spotlights Dr. Sara Herman

Soft Reboot Wellness, situated in the Bay Area’s Menlo Park, recently garnered attention from the Palo Alto Daily, shedding light on the groundbreaking work led by Dr. Sara Herman. As the founder of Soft Reboot Wellness, Dr. Sara’s expertise and commitment to mental health have been recognized as a beacon of hope in the bustling landscape of Silicon Valley.

Silicon Valley’s Sanctuary for Mental Wellness

The Palo Alto Daily feature delves into Soft Reboot Wellness as a sanctuary providing evidence-based ketamine therapy. Dr. Sara, a Harvard-trained anesthesiologist, brings her extensive medical background to the forefront, emphasizing the center’s dedication to addressing various mental health conditions.

Transformative Ketamine Therapy

Soft Reboot Wellness stands out for its holistic approach to mental wellness, offering ketamine therapy that goes beyond traditional treatments. The spotlight highlights how this therapy supports individuals dealing with treatment-resistant depression, anxiety, post-traumatic stress syndrome, burnout, and chronic pain. Moreover, it serves as a catalyst for personal growth and resilience during life transitions.

Dr. Sara Herman: A Visionary in Mental Health

The feature provides insights into Dr. Sara Herman’s journey—from her years as a board-certified anesthesiologist to the establishment of Soft Reboot Wellness in 2020. Driven by the stress of the COVID-19 pandemic, Dr. Sara’s shift towards mental health reflects a commitment to sharing the benefits of ketamine therapy.

“It’s a deep dive into yourself to figure out at the core who you are, what’s important to you and how to live authentically,” said Soft Reboot Wellness founder Dr. Sara Herman.

Dispelling Myths About Ketamine

Addressing common misconceptions, the Palo Alto Daily spotlights the safety and efficacy of ketamine therapy. While some may associate ketamine with illicit party use, the feature emphasizes its long and safe history as a widely used anesthetic medicine. Scientific research supporting low-dose ketamine infusions as a method to “reboot” the brain for mental health treatment is also highlighted.

A Journey of Healing at Soft Reboot

Soft Reboot’s careful screening process and guided therapy sessions are detailed in the spotlight. Clients are invited to embark on a transformative experience, reclining in zero-gravity chairs amidst curated music and aromatherapy. The journey of healing and self-discovery is emphasized, with Dr. Sara recommending a commitment to at least two sessions for optimal results.

Ready to Explore Ketamine Therapy?

Concluding the feature, readers are encouraged to learn more about Soft Reboot Wellness and ketamine therapy by contacting the center at (650) 419-3330 or visiting softrebootwellness.com. As Silicon Valley embraces innovation in mental health, Soft Reboot Wellness and Dr. Sara Herman stand as beacons of progress, providing a transformative path to mental well-being.

In the limelight of the Palo Alto Daily, Soft Reboot Wellness continues to make waves, shaping the narrative of mental wellness in Silicon Valley.

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Soft Reboot Wellness and Dr. Sara Herman Shine in the Palo Alto Daily Spotlight appeared first on Soft Reboot Wellness.

In a pioneering partnership, Soft Reboot Wellness, led by Dr. Sara Herman, proudly announces its collaboration with Enthea, a forefront player in employee benefits for Ketamine-Assisted Therapy (KAT). This initiative marks a significant step in revolutionizing mental health care for workplaces across the Bay Area, offering groundbreaking and accessible treatment options.

Enthea: Setting the Bar in Psychedelic Healthcare Benefits

Enthea emerges as a leader in the field of psychedelic healthcare, specializing in bespoke benefit plans that emphasize equitable access to quality care. Boasting a network of experienced ketamine therapy practitioners, Enthea’s plans are particularly appealing for forward-thinking companies prioritizing their workforce’s mental well-being. The benefits are clear: from reducing medical costs to boosting productivity and enhancing employee retention, Enthea’s approach to mental health care is transforming the corporate landscape.

Dr. Sara Herman’s Soft Reboot Wellness: A Holistic Approach

Under the leadership of Dr. Sara Herman, Soft Reboot Wellness is dedicated to offering a holistic approach to mental health. The clinic provides a variety of services, including preparation, integration, and internal family system coaching, all reflecting the principles of comprehensive, whole-person care. Unique treatments like ultrasound-guided stellate ganglion blocks for clients with PTSD exemplify the clinic’s innovative approach.

“We are committed to providing top-tier mental health services and overcoming significant barriers to effective treatment for conditions such as anxiety, depression, and trauma,” Dr. Herman states. “Our collaboration with Enthea perfectly aligns with our vision of offering holistic and pioneering treatments, including psychedelic-assisted therapy.”

A Unified Vision for Mental Health Wellness

Sherry Rais, CEO and co-founder of Enthea, reflects similar sentiments: “Our partnership with Soft Reboot Wellness is a crucial step in enabling businesses in the Bay Area to offer these advanced treatments. Dr. Herman’s expertise in integrative and holistic medicine, along with our collaborative efforts, will significantly mitigate the impacts of mental health disorders in the workplace.”

This partnership goes beyond providing services; it’s about reshaping the way mental health care is perceived and delivered in the workplace. With coverage extending to employees and their families, Soft Reboot Wellness and Enthea are set to make a profound impact in the Bay Area and beyond.

Stay tuned as we lead the way in transforming employee mental health care, one innovative step at a time.

Check out the Press Release here.

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Ketamine-Assisted Therapy: Revolutionizing Mental Health in the Bay Area appeared first on Soft Reboot Wellness.

In light of recent news regarding the tragic passing of Matthew Perry, we extend our deepest condolences to his friends, family, loved ones, and fans. His loss is a stark reminder of the complexities surrounding mental health and substance use. We feel it is our responsibility to address any concerns you might have about the safety and efficacy of IV ketamine therapy in a clinical setting, specifically at Soft Reboot Wellness.

Ketamine, when used under medical supervision, is administered with utmost care and precision. The controlled clinical environment at Soft Reboot Wellness in the Bay Area is significantly different from scenarios where ketamine might be used recreationally. At our clinic, Dr. Sara ensures that the dosage used is appropriate for therapeutic purposes and closely monitors the IV ketamine treatment process.

Our team, led by Dr. Sara, consists of experienced healthcare professionals who oversee every IV ketamine treatment session. This supervision is crucial in maintaining the safety and effectiveness of the therapy.

The dosages used in IV ketamine therapy at Soft Reboot Wellness are carefully calculated and are generally much lower than those associated with non-medical use. These dosages are adjusted to suit each individual’s specific health needs.

IV ketamine therapy is a part of a comprehensive treatment plan at Soft Reboot Wellness, Bay Area. It is not an isolated solution but a component of a holistic approach to mental health care.

We follow stringent safety protocols, including thorough client screening, continuous monitoring during IV ketamine treatment, and post-treatment care to ensure the best possible outcomes.

We understand the concerns that arise from news stories, especially those involving loss and grief. We want to reassure you that the use of IV ketamine therapy in a medical setting at Soft Reboot Wellness, under the care of Dr. Sara, is distinct and far removed from its recreational use.

If you have any questions or need further clarification about IV ketamine therapy at Soft Reboot Wellness in the Bay Area with Dr. Sara, please feel free to reach out. Our commitment is to your health and well-being, and we are here to support you through your journey.

With heartfelt sympathy and commitment to care,

Dr. Sara and The Soft Reboot Wellness Team

Reviewed by Dr. Sara Herman

Medical Disclaimer: The information in this blog is for educational purposes only and does not constitute medical advice. Ketamine therapy should only be pursued under the supervision of a licensed medical provider familiar with your full medical and psychiatric history. Individual results vary. Off-label treatments like IV ketamine for mental health conditions carry risks that should be discussed thoroughly with a qualified provider before beginning. If you are experiencing a mental health crisis or thoughts of self-harm, please call or text 988 to reach the Suicide and Crisis Lifeline or go to your nearest emergency room.

The post Addressing Concerns: Ketamine Therapy in Clinical Settings – Ensuring Safety and Efficacy appeared first on Soft Reboot Wellness.